CN1282583A - Exterior-applied ointment - Google Patents
Exterior-applied ointment Download PDFInfo
- Publication number
- CN1282583A CN1282583A CN 99111182 CN99111182A CN1282583A CN 1282583 A CN1282583 A CN 1282583A CN 99111182 CN99111182 CN 99111182 CN 99111182 A CN99111182 A CN 99111182A CN 1282583 A CN1282583 A CN 1282583A
- Authority
- CN
- China
- Prior art keywords
- grams
- white vaseline
- powder
- prednisone
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
An exterior-applied ointment for treating oral ulcer, simple lip herpes, ulcer caused by deep skin infection and other surgical infections contains prednisone, aureomycin, dicaine, VA and white vaseline.
Description
The invention relates to the invention of externally-applied soft ointment, this ointment can be used for treating the diseases such as ulcer that oral ulcer, lip herpes simplex and skin deep part tissue infection cause, belongs to drug world.
Oral ulcer is a kind of stubborn disease of repeatability outbreak, and this sick sickness rate is higher, be difficult to cure, and outbreak repeatedly, even reach 10 years, lack this sick specific medicament of radical cure at present.The simple sex vesicle rash morbidity of lip is rapid, and it is slower to disappear, and easily outbreak repeatedly is difficult to treatment, causes infection easily.The ulcer that the skin deep part tissue infection causes also is the disease that is difficult to cure.Therefore, the inventor has invented a kind of externally-applied soft ointment that can treat above-mentioned disease through for many years clinical summary and observation.
The object of the invention provides a kind of externally-applied ointment for the treatment of the diseases such as ulcer that oral ulcer, lip herpes simplex and skin deep part tissue infection cause.
Consisting of of medicine of the present invention:
Prednisone powder 7-15 gram
Chlortetracycline powder 23-48 gram
Dicaine powder 18-32 gram
Ten thousand units of vitamin A liquid 8,000,000 units-2000
White vaseline 1000 grams-3000 grams
The method for making of medicine of the present invention is as follows:
Earlier with prednisone powder, chlortetracycline powder, dicaine powder mix homogeneously, porphyrize adds the white vaseline of vitamin A liquid and part then again, gradually white vaseline is all added after grinding evenly, grind evenly ointment.
Medicine of the present invention can be treated oral ulcer, lip herpes simplex, reach the ulcer that the skin deep part tissue infection causes, curative effect highly significant and rapid, medication is pain relieving rapidly after about 5 minutes, reaches the effect of anti-inflammatory analgetic gradually, and the place can see fresh normal structure ramp in skin ulcer face cleaning, reach the limit and drain the effect of refuse limit growth flesh tissue, when the refuse emptying, the skin ulcer face can be repaired rapidly, reaches recovery from illness.Through 8 over thousands of routine patient treatments, obtained satisfied curative effect.
In addition, this ointment is to other position trauma infection contaminations of human body, formed surgical diseases such as deep tissue ulcer person, furuncle, onychitis, cellulitis, allergic dermatitis, eczema, the tinea manuum, tinea pedis, hemorrhoid infection, proctoptosis as scratch, scald postoperative infection, curative effect is also splendid.
Embodiment 1
Prednisone powder 7 grams
Chlortetracycline powder 23 grams
Dicaine powder 18 grams
Vitamin A liquid 8,000,000 units
White vaseline 1000 grams
With prednisone powder, chlortetracycline powder, dicaine powder mix homogeneously, porphyrize adds vitamin A liquid and part white vaseline then again, gradually white vaseline is all added after grinding evenly, grind evenly oral cavity and trauma ulcer ointment.
Embodiment 2
Prednisone powder 15 grams
Chlortetracycline powder 48 grams
Dicaine powder 32 grams
Vitamin A liquid 2,000 ten thousand units
White vaseline 3000 grams
With prednisone powder, chlortetracycline powder, dicaine powder mix homogeneously, porphyrize adds vitamin A liquid and part white vaseline then again, gradually white vaseline is all added after grinding evenly, grind evenly oral cavity and trauma ulcer ointment.
Claims (4)
1. externally-applied ointment is characterized in that it is made up of following component:
Prednisone 7-15 gram
Chlortetracycline 23-48 gram
Tetracaine 18-32 gram
Ten thousand units of vitamin A liquid 8,000,000 units-2000
White vaseline 1000 grams-3000 grams.
2. a kind of externally-applied ointment as claimed in claim 1 is characterized in that it is made up of following component:
Prednisone 7 grams
Chlortetracycline 23 grams
Tetracaine 18 grams
Vitamin A liquid 8,000,000 units
White vaseline 1000 grams.
3. a kind of externally-applied ointment as claimed in claim 1 is characterized in that it is made up of following component:
Prednisone 15 grams
Chlortetracycline 48 grams
Tetracaine 32 grams
Vitamin A liquid 2,000 ten thousand units
White vaseline 3000 grams.
4. the preparation method of the described a kind of externally-applied ointment of claim 1:
(1) a kind of externally-applied ointment, it is made up of following component:
Prednisone 7-15 gram
Chlortetracycline 23-48 gram
Tetracaine 18-32 gram
Ten thousand units of vitamin A liquid 8,000,000 units-2000
White vaseline 1000 grams-3000 grams;
(2) earlier with prednisone powder, chlortetracycline powder, dicaine powder mix homogeneously, porphyrize adds vitamin A liquid and part white vaseline then again, gradually white vaseline is all added after grinding evenly, grind evenly ointment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 99111182 CN1117570C (en) | 1999-07-29 | 1999-07-29 | Exterior-applied ointment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 99111182 CN1117570C (en) | 1999-07-29 | 1999-07-29 | Exterior-applied ointment |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1282583A true CN1282583A (en) | 2001-02-07 |
CN1117570C CN1117570C (en) | 2003-08-13 |
Family
ID=5274935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 99111182 Expired - Fee Related CN1117570C (en) | 1999-07-29 | 1999-07-29 | Exterior-applied ointment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1117570C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101375837B (en) * | 2008-10-09 | 2012-09-05 | 陈光爱 | Medicament composition for treating dermatopathy as well as preparation method and use thereof |
CN108969618A (en) * | 2018-08-18 | 2018-12-11 | 万明君 | A kind of externally-applied ointment for treating herpes diseases |
-
1999
- 1999-07-29 CN CN 99111182 patent/CN1117570C/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101375837B (en) * | 2008-10-09 | 2012-09-05 | 陈光爱 | Medicament composition for treating dermatopathy as well as preparation method and use thereof |
CN108969618A (en) * | 2018-08-18 | 2018-12-11 | 万明君 | A kind of externally-applied ointment for treating herpes diseases |
Also Published As
Publication number | Publication date |
---|---|
CN1117570C (en) | 2003-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2152398A1 (en) | Hyaluronic acid-urea pharmaceutical compositions and uses | |
CN1117570C (en) | Exterior-applied ointment | |
CN1562106A (en) | Paste for treating shank ulcer and bedsore | |
CN1053824C (en) | Exterior-use traditional Chinese medicine ointment and its preparing method | |
CN1172700C (en) | External applied medicine for curing burn and preparing method thereof | |
EP2052733A1 (en) | Herbal extracts for treatment of chronic wounds | |
Hollander et al. | Using an esterified hyaluronan fleece to promote healing in difficult-to-treat wounds | |
CN1058624C (en) | Burns curing powder and its preparation | |
RU2804915C1 (en) | Method for treating soft tissue wounds with high-pressure microdisperse treatment with molecular hydrogen-enriched water | |
CN1044778C (en) | Suppurative wound treating medicine for domestic animal | |
CN1236798C (en) | External medicine for treating bone tuberculosis | |
CN1167430C (en) | Broad-spectrum antibacterial Huangru Ointment for treating deep burn | |
EP3972561B1 (en) | Preparation for use in the therapeutic treatment of ulcerated skin lesions, wherein the preparation is administered topically and relative growth factor | |
CN1229117C (en) | Hircus treating medicament | |
CN1056293C (en) | Chinese medicine | |
CN1660292A (en) | Plaster for treating trauma and preparation method | |
CN1202358A (en) | Medicinal liquid and ointment for curing ache folliculitis and eczema | |
CN1843375A (en) | Traditional Chinese medicine for treating lower limb ulcer | |
CN1299697C (en) | Chinese medicine preparation for treating acne and its preparing method | |
Thenmozhi et al. | Hyperbaric oxygen therapy: Therapeutic role in various cases–A case series | |
CN1121870C (en) | Exterior-applied medicine 'Xiaobaiwang' for treating leukoderma and its preparing process | |
JP2004520391A (en) | Cyanoacrylate composition for preventing or treating diseases that manifest themselves and / or damage to skin tissue | |
CN1165331C (en) | Chinese medicine for treating tuberculosis | |
RU1805962C (en) | Method for treating angina | |
CN113952364A (en) | External anti-inflammation preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030813 Termination date: 20140729 |
|
EXPY | Termination of patent right or utility model |